DOWNREGULATION OF INFLAMMATORY MICRORNAS BY ILT3

It has been discovered that inhibition of two or more specific inflammatory miRs (30b, 21, 146a, and 155) suppresses T cell proliferation, promotes T cell anergy or induces the formation of suppressor T cells, thereby providing a focused therapy with minimal toxicity for disorders associated with ab...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SUCIU-FOCA, NICOLE, CHANG, CHIHAO, HO, ERIC, KOONMING, VLAD, GEORGE
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator SUCIU-FOCA, NICOLE
CHANG, CHIHAO
HO, ERIC, KOONMING
VLAD, GEORGE
description It has been discovered that inhibition of two or more specific inflammatory miRs (30b, 21, 146a, and 155) suppresses T cell proliferation, promotes T cell anergy or induces the formation of suppressor T cells, thereby providing a focused therapy with minimal toxicity for disorders associated with abnormally high immune responses. The corollary involves increasing the level of certain proinflammatory miRs thereby providing methods for immuno stimulation. It has also been discovered that significant increases of serum miR21 which occur in heart allograft rejection can be used to identify patients that have this disorder without requiring a biopsy. On s'est aperçu que l'inhibition d'au moins deux miARN inflammatoires spécifiques (30b, 21, 146a et 155) inhibe la prolifération des lymphocytes T, renforce l'énergie des lymphocytes T ou induit la formation de lymphocytes T suppresseurs, ce qui assure un traitement ciblé, caractérisé par une toxicité minimale, contre les affections associées à une réponse immunitaire anormalement forte. Le corollaire implique une augmentation du niveau de certains miARN pro-inflammatoires, ce qui peut constituer le fondement de méthodes d'immunostimulation. On s'est également aperçu que des augmentations significatives des miARN21 sériques qui se produisent lors du rejet d'une allogreffe cardiaque peuvent être utilisées pour identifier les patients souffrant de cette affection sans qu'il soit nécessaire de procéder à une biopsie.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2013036282A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2013036282A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2013036282A23</originalsourceid><addsrcrecordid>eNrjZDBw8Q_3C3J1D_VxDPH091Pwd1Pw9HPzcfT1dQzxD4pU8PV0DvIP8nMMVnCKVPD0CTHmYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXx4f5GBobGBsZmRhZGjkbGxKkCAOKFJ14</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>DOWNREGULATION OF INFLAMMATORY MICRORNAS BY ILT3</title><source>esp@cenet</source><creator>SUCIU-FOCA, NICOLE ; CHANG, CHIHAO ; HO, ERIC, KOONMING ; VLAD, GEORGE</creator><creatorcontrib>SUCIU-FOCA, NICOLE ; CHANG, CHIHAO ; HO, ERIC, KOONMING ; VLAD, GEORGE</creatorcontrib><description>It has been discovered that inhibition of two or more specific inflammatory miRs (30b, 21, 146a, and 155) suppresses T cell proliferation, promotes T cell anergy or induces the formation of suppressor T cells, thereby providing a focused therapy with minimal toxicity for disorders associated with abnormally high immune responses. The corollary involves increasing the level of certain proinflammatory miRs thereby providing methods for immuno stimulation. It has also been discovered that significant increases of serum miR21 which occur in heart allograft rejection can be used to identify patients that have this disorder without requiring a biopsy. On s'est aperçu que l'inhibition d'au moins deux miARN inflammatoires spécifiques (30b, 21, 146a et 155) inhibe la prolifération des lymphocytes T, renforce l'énergie des lymphocytes T ou induit la formation de lymphocytes T suppresseurs, ce qui assure un traitement ciblé, caractérisé par une toxicité minimale, contre les affections associées à une réponse immunitaire anormalement forte. Le corollaire implique une augmentation du niveau de certains miARN pro-inflammatoires, ce qui peut constituer le fondement de méthodes d'immunostimulation. On s'est également aperçu que des augmentations significatives des miARN21 sériques qui se produisent lors du rejet d'une allogreffe cardiaque peuvent être utilisées pour identifier les patients souffrant de cette affection sans qu'il soit nécessaire de procéder à une biopsie.</description><language>eng ; fre</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC ; GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPIRITS ; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS ; TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE ; TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINSTCLIMATE CHANGE ; VINEGAR ; WINE</subject><creationdate>2013</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20130314&amp;DB=EPODOC&amp;CC=WO&amp;NR=2013036282A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76418</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20130314&amp;DB=EPODOC&amp;CC=WO&amp;NR=2013036282A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SUCIU-FOCA, NICOLE</creatorcontrib><creatorcontrib>CHANG, CHIHAO</creatorcontrib><creatorcontrib>HO, ERIC, KOONMING</creatorcontrib><creatorcontrib>VLAD, GEORGE</creatorcontrib><title>DOWNREGULATION OF INFLAMMATORY MICRORNAS BY ILT3</title><description>It has been discovered that inhibition of two or more specific inflammatory miRs (30b, 21, 146a, and 155) suppresses T cell proliferation, promotes T cell anergy or induces the formation of suppressor T cells, thereby providing a focused therapy with minimal toxicity for disorders associated with abnormally high immune responses. The corollary involves increasing the level of certain proinflammatory miRs thereby providing methods for immuno stimulation. It has also been discovered that significant increases of serum miR21 which occur in heart allograft rejection can be used to identify patients that have this disorder without requiring a biopsy. On s'est aperçu que l'inhibition d'au moins deux miARN inflammatoires spécifiques (30b, 21, 146a et 155) inhibe la prolifération des lymphocytes T, renforce l'énergie des lymphocytes T ou induit la formation de lymphocytes T suppresseurs, ce qui assure un traitement ciblé, caractérisé par une toxicité minimale, contre les affections associées à une réponse immunitaire anormalement forte. Le corollaire implique une augmentation du niveau de certains miARN pro-inflammatoires, ce qui peut constituer le fondement de méthodes d'immunostimulation. On s'est également aperçu que des augmentations significatives des miARN21 sériques qui se produisent lors du rejet d'une allogreffe cardiaque peuvent être utilisées pour identifier les patients souffrant de cette affection sans qu'il soit nécessaire de procéder à une biopsie.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC</subject><subject>GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPIRITS</subject><subject>TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS</subject><subject>TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE</subject><subject>TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINSTCLIMATE CHANGE</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2013</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDBw8Q_3C3J1D_VxDPH091Pwd1Pw9HPzcfT1dQzxD4pU8PV0DvIP8nMMVnCKVPD0CTHmYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXx4f5GBobGBsZmRhZGjkbGxKkCAOKFJ14</recordid><startdate>20130314</startdate><enddate>20130314</enddate><creator>SUCIU-FOCA, NICOLE</creator><creator>CHANG, CHIHAO</creator><creator>HO, ERIC, KOONMING</creator><creator>VLAD, GEORGE</creator><scope>EVB</scope></search><sort><creationdate>20130314</creationdate><title>DOWNREGULATION OF INFLAMMATORY MICRORNAS BY ILT3</title><author>SUCIU-FOCA, NICOLE ; CHANG, CHIHAO ; HO, ERIC, KOONMING ; VLAD, GEORGE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2013036282A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2013</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC</topic><topic>GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPIRITS</topic><topic>TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS</topic><topic>TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE</topic><topic>TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINSTCLIMATE CHANGE</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>SUCIU-FOCA, NICOLE</creatorcontrib><creatorcontrib>CHANG, CHIHAO</creatorcontrib><creatorcontrib>HO, ERIC, KOONMING</creatorcontrib><creatorcontrib>VLAD, GEORGE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SUCIU-FOCA, NICOLE</au><au>CHANG, CHIHAO</au><au>HO, ERIC, KOONMING</au><au>VLAD, GEORGE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>DOWNREGULATION OF INFLAMMATORY MICRORNAS BY ILT3</title><date>2013-03-14</date><risdate>2013</risdate><abstract>It has been discovered that inhibition of two or more specific inflammatory miRs (30b, 21, 146a, and 155) suppresses T cell proliferation, promotes T cell anergy or induces the formation of suppressor T cells, thereby providing a focused therapy with minimal toxicity for disorders associated with abnormally high immune responses. The corollary involves increasing the level of certain proinflammatory miRs thereby providing methods for immuno stimulation. It has also been discovered that significant increases of serum miR21 which occur in heart allograft rejection can be used to identify patients that have this disorder without requiring a biopsy. On s'est aperçu que l'inhibition d'au moins deux miARN inflammatoires spécifiques (30b, 21, 146a et 155) inhibe la prolifération des lymphocytes T, renforce l'énergie des lymphocytes T ou induit la formation de lymphocytes T suppresseurs, ce qui assure un traitement ciblé, caractérisé par une toxicité minimale, contre les affections associées à une réponse immunitaire anormalement forte. Le corollaire implique une augmentation du niveau de certains miARN pro-inflammatoires, ce qui peut constituer le fondement de méthodes d'immunostimulation. On s'est également aperçu que des augmentations significatives des miARN21 sériques qui se produisent lors du rejet d'une allogreffe cardiaque peuvent être utilisées pour identifier les patients souffrant de cette affection sans qu'il soit nécessaire de procéder à une biopsie.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_WO2013036282A2
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC
GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINSTCLIMATE CHANGE
VINEGAR
WINE
title DOWNREGULATION OF INFLAMMATORY MICRORNAS BY ILT3
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T22%3A19%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SUCIU-FOCA,%20NICOLE&rft.date=2013-03-14&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2013036282A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true